News Industry News Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate) November 29, 2015
News Daily News Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves Caitlin E. Cox November 26, 2015
News Daily News Amid Push-Back, Direct Industry Sponsorship of Physicians on Its Way Out in Europe Todd Neale November 25, 2015
News Industry News XENIOS® AG receives CE mark for its i-cor® Synchronized Cardiac Assist System November 24, 2015